Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2024)
Dianthus Therapeutics (DNTH) has 5 years of Receivables - Other data on record, last reported at $807000.0 in Q4 2024.
- For Q4 2024, Receivables - Other rose 303.5% year-over-year to $807000.0; the TTM value through Dec 2024 reached $807000.0, up 303.5%, while the annual FY2024 figure was $200000.0, 0.0% changed from the prior year.
- Receivables - Other reached $807000.0 in Q4 2024 per DNTH's latest filing, down from $1.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.3 million in Q3 2024 and bottomed at $200000.0 in Q4 2023.
- Average Receivables - Other over 3 years is $703714.3, with a median of $800000.0 recorded in 2024.
- Peak YoY movement for Receivables - Other: plummeted 77.78% in 2023, then soared 303.5% in 2024.
- A 3-year view of Receivables - Other shows it stood at $900000.0 in 2022, then tumbled by 77.78% to $200000.0 in 2023, then skyrocketed by 303.5% to $807000.0 in 2024.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $807000.0 in Q4 2024, $1.3 million in Q3 2024, and $800000.0 in Q2 2024.